What is the role of positron emission tomography (PET) scanning in the workup of multiple system atrophy (MSA)?

Updated: Oct 17, 2018
  • Author: André Diedrich, MD, PhD; Chief Editor: Selim R Benbadis, MD  more...
  • Print
Answer

MSA can be differentiated from Parkinson disease with the use of FDG-PET scanning. The caudate-putamen index, which is calculated using a formula based on the difference in the uptakes in the caudate and putamen divided by the caudate uptake, is lower in patients with MSA than in patients with Parkinson disease. [36]

Expected findings in MSA are as follows:

  • Reduced putaminal FDG uptake

  • Reduced [11 C]raclopride and [11 C]diprenorphine levels

  • Reduced cerebellar glucose metabolism in OPCA

Absence of parkinsonian features but evidence of striatonigral dopaminergic denervation may point to MSA.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!